Search research articles
Contact Us
Filters
Showing results (171-180 of 176) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 176 results.
Medical Physics
|
November 23, 2024
The TROG 15.01 stereotactic prostate adaptive radiotherapy utilizing kilovoltage intrafraction monitoring (SPARK) clinical trial database
Chandrima Sengupta, Doan Trang Nguyen, Yifan Li, et al.
The Lancet. Oncology
|
February 29, 2024
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Shankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet. Oncology
|
May 17, 2026
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study
Shankar Siva, David Pryor, Jarad Martin, et al.
Medical Physics
|
December 22, 2018
The VAMPIRE challenge: A multi-institutional validation study of CT ventilation imaging
John Kipritidis, Bilal A Tahir, Guillaume Cazoulat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 7, 2024
Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios
Nicholas Hardcastle, Eliana Vasquez Osorio, Andrew Jackson, et al.
BMC Cancer
|
July 7, 2024
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)
Alan Wigg, Jonathan Tibballs, Richard Woodman, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 176) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 176 results.
Medical Physics
|
November 23, 2024
The TROG 15.01 stereotactic prostate adaptive radiotherapy utilizing kilovoltage intrafraction monitoring (SPARK) clinical trial database
Chandrima Sengupta, Doan Trang Nguyen, Yifan Li, et al.
The Lancet. Oncology
|
February 29, 2024
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Shankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet. Oncology
|
May 17, 2026
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study
Shankar Siva, David Pryor, Jarad Martin, et al.
Medical Physics
|
December 22, 2018
The VAMPIRE challenge: A multi-institutional validation study of CT ventilation imaging
John Kipritidis, Bilal A Tahir, Guillaume Cazoulat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 7, 2024
Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios
Nicholas Hardcastle, Eliana Vasquez Osorio, Andrew Jackson, et al.
BMC Cancer
|
July 7, 2024
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)
Alan Wigg, Jonathan Tibballs, Richard Woodman, et al.
Page
of 18